Pharma Mirror Magazine

Eisai: All-case Surveillance Condition for Approval of “Actonel 17.5 mg tablets” for Treatment of Paget’s Disease of Bone Cleared in Japan

March 19, 2020

EA Pharma Co., Ltd. and its parent company Eisai Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare

March 19, 2020

NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) a leader in the development of highly effective antiviral therapies based on a

March 17, 2020

There are many contradictions of using vitamins and supplements for a variety of health concerns. Some work fine, some do

March 13, 2020

Following the announcement by Messe Duesseldorf that interpack 2020, which was scheduled for May, will be postponed to next year,

March 13, 2020

The €6.3 million, four-year new joint research project aims to develop microbiome-based solutions to establish a healthy microbiome in early

March 13, 2020

Urge incontinence occurs when someone experiences a sudden strong need to urinate but cannot reach the washroom in time to